Intravenous drips in dermatology: Elixir, evidence, or ethical dilemma?
Cosmoderma · 2025
DOI: 10.25259/csdm_101_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cosmoderma, 2025. Verfasst von Savi Aneja und 1 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
The use of intravenous (IV) drips in dermatology, once limited to inpatient management of acute conditions, has now found a growing niche in esthetic and wellness practices. From glutathione for fairness to multivitamin glow drips, IV therapies are increasingly being marketed to patients seeking quick cosmetic improvements. While there may be some scientific rationale for IV therapy in specific dermatological scenarios, the widespread esthetic use remains largely unregulated and lacks strong clinical evidence. This article discusses the role of IV drips in dermatology, the ethical boundaries of such interventions, and the urgent need for evidence-based guidelines and regulations.
Zitieren
APA
Aneja, S., & Kumar, R. (2025). Intravenous drips in dermatology: Elixir, evidence, or ethical dilemma?. Cosmoderma. https://doi.org/10.25259/csdm_101_2025
Vancouver
Aneja S, Kumar R. Intravenous drips in dermatology: Elixir, evidence, or ethical dilemma?. Cosmoderma. 2025. doi:10.25259/csdm_101_2025
BibTeX
@article{Aneja2025,
author = {Aneja, Savi and Kumar, Ravi},
title = {Intravenous drips in dermatology: Elixir, evidence, or ethical dilemma?},
journal = {Cosmoderma},
year = {2025},
doi = {10.25259/csdm_101_2025}
}
EUVIMED